These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
177 related articles for article (PubMed ID: 33095651)
61. Desensitization by neuropeptide Y of effects of sympathetic stimulation on cardiac vagal action in anaesthetised dogs. Moriarty M; Potter EK; McCloskey DI J Auton Nerv Syst; 1993 Oct; 45(1):21-8. PubMed ID: 8227962 [TBL] [Abstract][Full Text] [Related]
62. NPY Y2 receptor agonist, N-acetyl [Leu28,Leu31]NPY24-36, reduces renal vasoconstrictor activity in anaesthetised dogs. Mahns DA; Kelly C; McCloskey DI; Potter EK J Auton Nerv Syst; 1999 Oct; 78(1):10-7. PubMed ID: 10589818 [TBL] [Abstract][Full Text] [Related]
63. Epinephrine in the heart: uptake and release, but no facilitation of norepinephrine release. Lameris TW; de Zeeuw S; Duncker DJ; Tietge W; Alberts G; Boomsma F; Verdouw PD; van den Meiracker AH Circulation; 2002 Aug; 106(7):860-5. PubMed ID: 12176961 [TBL] [Abstract][Full Text] [Related]
64. Neuropeptide Y and differential sympathetic control of splenic blood flow and capacitance function in the pig and dog. Modin A; Pernow J; Lundberg JM Acta Physiol Scand; 1993 Jan; 147(1):15-25. PubMed ID: 8095766 [TBL] [Abstract][Full Text] [Related]
65. Effects of intense antecedent sympathetic stimulation on sympathetic neurotransmission in the heart. Yang T; Levy MN Circ Res; 1993 Jan; 72(1):137-44. PubMed ID: 8380260 [TBL] [Abstract][Full Text] [Related]
66. Region-specific neuropeptide Y overflows at rest and during sympathetic activation in humans. Morris MJ; Cox HS; Lambert GW; Kaye DM; Jennings GL; Meredith IT; Esler MD Hypertension; 1997 Jan; 29(1 Pt 1):137-43. PubMed ID: 9039093 [TBL] [Abstract][Full Text] [Related]
67. Neuropeptide Y and non-adrenergic sympathetic vascular control of the cat nasal mucosa. Lundblad L; Anggard A; Saria A; Lundberg JM J Auton Nerv Syst; 1987 Oct; 20(3):189-97. PubMed ID: 3693801 [TBL] [Abstract][Full Text] [Related]
68. Neuropeptide Y and peptide YY mediate nonadrenergic vasoconstriction and modulate sympathetic responses in rats. Zukowska-Grojec Z; Haass M; Bayorh MA Regul Pept; 1986 Sep; 15(2):99-110. PubMed ID: 3786837 [TBL] [Abstract][Full Text] [Related]
69. Inhibition of cardiac vagal effects by neurally released and exogenous neuropeptide Y. Warner MR; Levy MN Circ Res; 1989 Dec; 65(6):1536-46. PubMed ID: 2582589 [TBL] [Abstract][Full Text] [Related]
71. Differential action of hepatic sympathetic neuropeptides: metabolic action of galanin, vascular action of NPY. Mundinger TO; Taborsky GJ Am J Physiol Endocrinol Metab; 2000 Mar; 278(3):E390-7. PubMed ID: 10710492 [TBL] [Abstract][Full Text] [Related]
72. Renal and cardiac neuropeptide Y and NPY receptors in a rat model of congestive heart failure. Callanan EY; Lee EW; Tilan JU; Winaver J; Haramati A; Mulroney SE; Zukowska Z Am J Physiol Renal Physiol; 2007 Dec; 293(6):F1811-7. PubMed ID: 17804485 [TBL] [Abstract][Full Text] [Related]
73. Inhibitory effect of neuropeptide Y on adrenergic and cholinergic transmission in rat urinary bladder and urethra. Tran LV; Somogyi GT; De Groat WC Am J Physiol; 1994 Apr; 266(4 Pt 2):R1411-7. PubMed ID: 8184986 [TBL] [Abstract][Full Text] [Related]
74. The cardiac sympathetic co-transmitter galanin reduces acetylcholine release and vagal bradycardia: implications for neural control of cardiac excitability. Herring N; Cranley J; Lokale MN; Li D; Shanks J; Alston EN; Girard BM; Carter E; Parsons RL; Habecker BA; Paterson DJ J Mol Cell Cardiol; 2012 Mar; 52(3):667-76. PubMed ID: 22172449 [TBL] [Abstract][Full Text] [Related]
75. Sympathetic regulation of skeletal muscle blood flow in the pig: a non-adrenergic component likely to be mediated by neuropeptide Y. Modin A; Pernow J; Lundberg JM Acta Physiol Scand; 1993 May; 148(1):1-11. PubMed ID: 8333291 [TBL] [Abstract][Full Text] [Related]
76. Effects of neuropeptide Y on the response of isolated blood vessels to norepinephrine and sympathetic field stimulation. Hieble JP; Duesler JG; Daly RN J Pharmacol Exp Ther; 1989 Aug; 250(2):523-8. PubMed ID: 2668503 [TBL] [Abstract][Full Text] [Related]
77. Changes in cardiac neuropeptide Y after experimental myocardial infarction in rat. Han C; Wang XA; Fiscus RR; Gu J; McDonald JK Neurosci Lett; 1989 Sep; 104(1-2):141-6. PubMed ID: 2812527 [TBL] [Abstract][Full Text] [Related]
78. NPY is not a primary mediator of the acute thyroid blood flow response to sympathetic nerve stimulation. Dey M; Michalkiewicz M; Huffman L; Hedge GA Am J Physiol; 1993 Jul; 265(1 Pt 1):E24-30. PubMed ID: 8338150 [TBL] [Abstract][Full Text] [Related]
79. Scalable and reversible axonal neuromodulation of the sympathetic chain for cardiac control. Hadaya J; Buckley U; Gurel NZ; Chan CA; Swid MA; Bhadra N; Vrabec TL; Hoang JD; Smith C; Shivkumar K; Ardell JL Am J Physiol Heart Circ Physiol; 2022 Jan; 322(1):H105-H115. PubMed ID: 34860595 [TBL] [Abstract][Full Text] [Related]
80. Segregation of the classical transmitters norepinephrine and acetylcholine and the neuropeptide Y in sympathetic neurons: modulation by ciliary neurotrophic factor or prolonged growth in culture. Vega A; Luther JA; Birren SJ; Morales MA Dev Neurobiol; 2010 Dec; 70(14):913-28. PubMed ID: 20715153 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]